Abbott India · NSE: ABBOTINDIA · BSE: 500488
Q3 FY23 results · Oct–Dec 2022
Abbott India reported revenue from operations of ₹1,326.48 crore (up 8.3% from Q3 FY22) and net profit of ₹246.83 crore (up 23.9% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a standalone basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,326.48 | 1,224.36 | +8.3% | 1,379.48 | −3.8% |
| Other income | 39.94 | 18.74 | +113.1% | 33.53 | +19.1% |
| Total income | 1,366.42 | 1,243.10 | +9.9% | 1,413.01 | −3.3% |
| Profit before tax | 334.83 | 266.65 | +25.6% | 355.39 | −5.8% |
| Net profit for the period | 246.83 | 199.20 | +23.9% | 265.52 | −7.0% |
| EPS, basic (₹) | 116.16 | 93.74 | +23.9% | 124.95 | −7.0% |
| Net margin (%) | 18.6 | 16.3 | 19.2 |
Standalone
- Filed with BSE
- 10 Feb 2023, 16:05 IST
- Board meeting
- 10 Feb 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE